Twenty years of clinical human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) in Hong Kong

Hong Kong Medical Journal

Volumn 12, Issue 2, 2006, Pages 133-140

  Wong, K H ^a   Chan, K C W ^a   Lee, S S ^b  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Acquired immunodeficiency syndrome; Antiretroviral therapy; Epidemiology; Highly active; HIV infections; Sexually transmitted diseases

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; DISEASE COURSE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HEMOPHILIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HONG KONG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LIPODYSTROPHY; LYMPHOMA; MEDICAL CARE; MEDICAL RESEARCH; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PENICILLIUM MARNEFFEI; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; RASH; REVIEW; SURVIVAL;

HIV INFECTIONS; HONG KONG; HUMANS; RESEARCH;

EID: 33646477717     PISSN: 10242708     EISSN: 10242708     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Centers for Disease Control (CDC). Pneumocystis pneumonia - Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-2.
2. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
3. Choi T, Lee SS. Tracking HIV infection: Hong Kong. AIDS Read 2000;10:29-34.
4. Wong KH, Lee SS, Ho KM. Lack of ageing cohort effect among sexually acquired HIV infections in Hong Kong. Int J STD AIDS 2003;14:42-5.
5. Wong KH, Lee SS, Low KH, Wan WY. Temporal trend and factors associated with late HIV diagnosis in Hong Kong, a low HIV prevalence locality. AIDS Patient Care STDS 2003;17:461-9.
6. Lee SS. Low perceived risk of HIV infection in Chinese patients in Hong Kong. Internat J Med 1996;1:14-7.
7. Lim WL, Xing H, Wong KH, et al. The lack of epidemiological link between the HIV type 1 infections in Hong Kong and Mainland China. AIDS Res Hum Retroviruses 2004;20:259-62.
8. Wong TY, So MK. Primary human immunodeficiency virus infection: heightened awareness needed. Hong Kong Med J 2001;7:205-8.
9. Li PC, Yeoh EK. AIDS in Hong Kong - the first twenty two cases. Journal of the Hong Kong Medical Association 1989;41:152-5.
10. Lee SS, Lo YC, Wong KH. The first one hundred AIDS cases in Hong Kong. Chin Med J (Engl) 1996;109:70-6.
11. Wong KH, Lee SS. Comparing the first and second hundred AIDS cases in Hong Kong. Singapore Med J 1998;39:236-40.
12. Wong KH, Lee SS, Lo YC, et al. Profile of opportunistic infections among HIV-1 infected people in Hong Kong. Zhonghua Yi Xue Za Zhi (Taipei) 1995;55:127-36.
13. So SY, Chau PY, Jones BM, et al. A case of invasive penicilliosis in Hong Kong with immunologic evaluation. Am Rev Respir Dis 1985;131:662-5.
14. Chang KC, Chan CK, Chow KC, Lam CW. Penicillium marneffei infection and solitary pulmonary nodule. Hong Kong Med J 1998;4:59-62.
15. Leung R, Sung JY, Chow J, Lai CK. Unusual cause of fever and diarrhea in a patient with AIDS. Penicillium marneffei infection. Dig Dis Sci 1996;41:1212-5.
16. Tong AC, Wong M, Smith NJ. Penicillium marneffei infection presenting as oral ulcerations in a patient infected with human immunodeficiency virus. J Oral Maxillofac Surg 2001;59:953-6.
17. Tsang DN, Li PC, Tsui MS, Lau YT, Ma KF, Yeoh EK. Penicillium marneffei: another pathogen to consider in patients infected with human immunodeficiency virus. Rev Infect Dis 1991;13:766-7.
18. Tsui WM, Ma KF, Tsang DN. Disseminated Penicillium marneffei infection in HIV-infected subject. Histopathology 1992;20:287-93.
19. Wong KF, Tsang DN, Chan JK. Bone marrow diagnosis of penicilliosis. N Engl J Med 1994;330:717-8.
20. So CC, Wong KF. Bone marrow penicilliosis. Br J Haematol 2002;117:777.
21. Wong SS, Wong KH, Hui WT, et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol 2001;39:4535-40.
22. Li PC, Tsui MC, Ma KF. Penicillium marneffei: indicator disease for AIDS in South East Asia. AIDS 1992;6:240-1.
23. Wong KH, Lee SS, Chan KC, Choi T. Redefining AIDS: case exemplified by Penicillium marneffei infection in HIV-infected people in Hong Kong. Int J STD AIDS 1998;9:555-6.
24. Tsang DN, Li PC, Ho HF, Lai RW. Mycobacterial diseases and AIDS in Hong Kong. Journal of the Hong Kong Medical Association 1994;46:102-5.
25. Lee MP, Chan JW, Ng KK, Li PC. Clinical manifestations of tuberculosis in HIV-infected patients. Respirology 2000;5:423-6.
26. Noertjojo K, Tam CM, Chan SL, Chan-Yeung MM. Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2002;6:879-86.
27. Li PC. Neurologic manifestations of AIDS - the Hong Kong experience. Journal of the Hong Kong Medical Association 1994;46:106-16.
28. Li PC. Cryptococcal meningitis in the AIDS era. Journal of the Hong Kong Medical Association 1993;45:27-32.
29. Wong KF, Ma SK, Chan JK, Lam KW. Acquired immunodeficiency syndrome presenting as marrow cryptococcosis. Am J Hematol 1993;42:392-4.
30. Ho PC, Farzavandi SK, Kwok SK, Lam DS, Li PC. Ophthalmic complications in AIDS in Hong Kong. Journal of the Hong Kong Medical Association 1994;46:117-21.
31. Tsang PC, Samaranayake LP. Oral manifestations of HIV infection in a group of predominantly ethnic Chinese. J Oral Pathol Med 1999;28:122-7.
32. Tsang CS, Samaranayake LP. Oral yeasts and coliforms in HIV-infected individuals in Hong Kong. Mycoses 2000;43:303-8.
33. Chan LY, Lee SS, Wong KH, Ng KK, Li PC. Kaposi's sarcoma in patients with the acquired immunodeficiency syndrome: the Hong Kong experience. Hong Kong Med J 1996;2:127-31.
34. Mak YK, Chan CH, Li CK, Lee MP, Tsang YW. Clinical profiles of human immunodeficiency virus-associated lymphoma in Hong Kong. Hong Kong Med J 2003;9:91-7.
35. Cheuk W, Li PC, Chan JK. Epstein-Barr virus-associated smooth muscle tumour: a distinctive mesenchymal tumour of immunocompromised individuals. Pathology 2002;34:245-9.
36. Wong KM, Liu YL, Leung KT, et al. Corticosteroid therapy in a Chinese patient with nephropathy associated with human immunodeficiency virus infection. Hong Kong Med J 2004;10:201-5.
37. Wong KH, Chow WS, Lee SS. Clinical hyperthyroidism in Chinese patients with stable HIV disease. Clin Infect Dis 2004;39:1257-9.
38. Ho MH, Chong LY, Ho TT. HIV-associated eosinophilic folliculitis in a Chinese woman: a case report and a survey in Hong Kong. Int J STD AIDS 1998;9:489-93.
39. Kam KM, Leung WL, Kwok MY, Hung MY, Lee SS, Mak WP. Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults. Clin Diagn Lab Immunol 1996;3:326-30.
40. Kam KM, Wong KH, Lee SS. Interpretation of CD4+ T-lymphocyte values in different HIV-infected populations. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:185-6.
41. Wong KH, Lee SS, Kam KM. Decline of CD4 level and its correlation with clinical events in Chinese HIV-infected patients. J Infect Dis Antimicrob Agents 1998;15:99-103.
42. Kam KM, Wong KH, Li PC, Lee SS, Leung WL, Kwok MY. Proposed CD4(+) T-cell criteria for staging human immunodeficiency virus-infected Chinese adults. Clin Immunol Immunopathol 1998;89:11-22.
43. Ho TT, Wong KH, Lee SS. Low yield of chest radiography in screening for active pulmonary tuberculosis in HIV-infected patients in Hong Kong. Int J STD AIDS 1999;10:409-12.
44. Chan KC, Tang HW, Wong K. Prevalence of purified protein derivative positivity in human immunodeficiency virus infected individuals in Hong Kong. Chin Med J (Engl) 2002;115:1091-2.
45. Wong KH, Lee SS, Li PC, Sitt WH, Ho HF, Lo YC. Anti-retroviral therapy for HIV Infection in Hong Kong. Journal of the Hong Kong Medical Association 1994;2:122-7.
46. Wong KH, Lee SS. Antiretroviral therapy for adult HIV infection - advances and implications. Hong Kong Pract 1998;20:120-30.
47. Ho CF, Fong OW, Wong KH. Patient self-report as a marker of adherence to antiretroviral therapy. Clin Infect Dis 2002;34:1534-5.
48. Fong OW, Ho CF, Fung LY, et al. Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. HIV Med 2003;4:133-8.
49. Molassiotis A, Nahas-Lopez V, Chung WY, Lam SW, Li CK, Lau TF. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS 2002;13:301-10.
50. Ho TT, Chan KC, Wong KH, Lee SS. Abnormal fat distribution and use of protease inhibitors. Lancet 1998;351:1736-7.
51. Ho TT, Chan KC, Wong KH, Lee SS. Indinavir-associated facial lipodystrophy in HIV-infected patients. AIDS Patient Care STDS 1999;13:11-6.
52. Ho TT, Wong KH, Chan KC, Lee SS. High incidence of nevirapine-associated rash in HIV-infected Chinese. AIDS 1998;12:2082-3.
53. Wong KH, Chan KC, Lee SS. Sex differences in nevirapine rash. Clin Infect Dis 2001;33:2096-8.
54. Wong KH, Chan KC, Lee SS. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Clin Infect Dis 2004;39:853-60.
55. Ho KM, Ho KK, Lim WL, Li P, Wong KH. Epidemiology and detection of human immunodeficiency virus among pregnant women in Hong Kong. Hong Kong Med J 2001;7:335-42.
56. Tse HY, Lai FK, Wong J, Chan AS, Tang LC. Universal screening of human immunodeficiency virus infection in pregnant women in Hong Kong: prospective study. Hong Kong Med J 2001;7:246-50.
57. Chiu SS, Lau YL. Perinatally acquired human immunodeficiency virus infection in children in Hong Kong: the experience of one centre. Hong Kong Journal of Paediatrics 2000;5:132-8.
58. Kam KM, Leung WL, Wong KH, Lee SS, Hung MY, Kwok MY. Maturational changes in peripheral lymphocyte subsets pertinent to monitoring human immunodeficiency virus-infected Chinese pediatric patients. Clin Diagn Lab Immunol 2001;8:926-31.
59. Lee SS, Wong KH, Dickinson AJ. Haemophilia and HIV infection in Hong Kong. AIDS Care 1996;8:365-72.
60. Lee CK, Hui CH, Lie AKW, Liang R, Chan TK. Clinical outcomes of HIV-infected haemophiliac patients in Hong Kong. Haemophilia 1997;3:20-8.
61. Wong KH, Lee SS, Choi MY, Lee CK, Lau YL. Non-progressors of HIV infection - Hong Kong Experience. Int J Infect Dis 1996;1:14-7.
62. Wong AT, Tsang OT, Wong MY, et al. Coronavirus infection in an AIDS patient. AIDS 2004;18:829-30.
63. Lundgren JD, Pedersen C, Clumeck N, et al. Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ 1994;308:1068-73.
64. Mocroft A, Youle M, Morcinek J, et al. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. BMJ 1997;314:409-13.
65. Whitman S, Murphy J, Cohen M, Sherer R. Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997. Arch Intern Med 2000;160:365-9.
66. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003;362:22-9.
67. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994;344:110-3.
68. Reichert T, DeBruyere M, Deneys V, et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 1991;60:190-208.
69. Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002;360:1921-6.
70. Rockstroh JK. Management of hepatitis B and C in HIV co-infected patients. J Acquir Immune Defic Syndr 2003;34(Suppl 1):59S-65S.
71. Wong KH, Lee SS, Chan KC. Screen for underlying HIV before antiviral treatment for HBV. J Infect 2005;51:172-3.
72. Tsiodras S, Mantzoros C, Hammer S, Samore M. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch Intern Med 2000;160:2050-6.
73. Stein JH, Klein MA, Bellehumeur JL, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001;104:257-62.